# Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients

> **NCT01333449** · PHASE2 · TERMINATED · sponsor: **Singapore General Hospital** · enrollment: 6 (actual)

## Conditions studied

- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT01333449
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Poor subject accrual
- **Last updated:** 2014-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01333449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01333449, "Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01333449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*